Top upfront cash licensing deals in '17 Bayer/Loxo Ph2

New Post Public Reply Private Reply Replies (4) Message Board
2718
862
Top upfront cash licensing deals in '17

Bayer/Loxo Ph2 $400M upfront Onc.

Novartis/Ions Ph2 $375M upfront Cardio' V

Nanjing Legend/Janssen Ph2 $350M upfront Onc

Biogen/Bristol Myers Ph1 $300M upfront Neurology

Merck/Vertex Ph2 $230M upfront Onc.

AbbV/Alector Discovery stage $205M upfront Neurology

Roche/Bristol Myers Ph1 $170M upfront Musculoskeletal

EliLilly/Nektar Ph1 $150M upfront Auto Imm/Inflam

Sanofi/Astrazeneca Ph2 $126M upfront Infection

Dermira/Roche Ph2 $80M upfront Dermatologic

Looks to me BP is wiling to pay up earlier

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials